Hemostasis Today

November, 2026
November 2026
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
30  
Ana Pedrero Gil: Navigating Anemia Management in Patients With Stroke or Malignancy History
May 14, 2026, 15:06

Ana Pedrero Gil: Navigating Anemia Management in Patients With Stroke or Malignancy History

Ana Pedrero Gil, Anesthesiologist at Igualada University Hospital, shared a post on LinkedIn, about a recent article by Rammdeep Saini, published in Canadian Journal of Kidney Health and Disease, adding:

“Erythropoiesis-stimulating agents (ESAs) are commonly used to manage chronic kidney disease (CKD) associated anemia.

There is a paucity of clear guidelines on their use in patients with CKD and with history of stroke or malignancy.”

Title: A Canadian Survey of Prescribing Practices of Erythropoiesis-Stimulating Agents in Dialysis-Dependent and Non-Dialysis-Dependent Chronic Kidney Disease

Authors: Rammdeep Saini, Keigan More, Jo-Anne S. Wilson, David A. Clark, Amanda J. Vinson, David Collister, Mark Canney, and Karthik K. Tennankore

Ana Pedrero Gil

Stay updated on all scientific advances with Hemostasis Today.